ACUT
Accustem Sciences Inc.
Key Financials
Net Income
$-1505102
↑ 26.6%
Operating Income
$-1505102
↑ 26.6%
Total Liabilities
$3.4M
↑ 49.8%
EPS (Diluted)
$-0.13
↑ 27.8%
Total Assets
$50851.00
↓ 62.0%
Shareholders' Equity
$-3313224.00
↓ 56.9%
Operating Cash Flow
$-664066.00
↑ 58.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ACUT |
| Company Name | Accustem Sciences Inc. |
| CIK | 1850767 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 442070661000 |